Showing results (41-50 of 226) with videos related to

Sort By:
Pageof 23
Clinical Pharmacology and Therapeutics|May 19, 2005
Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazoneTiina Jaakkola, Janne T Backman, Mikko Neuvonen, et al.
Basic & Clinical Pharmacology & Toxicology|July 27, 2006
Pioglitazone is metabolised by CYP2C8 and CYP3A4 in vitro: potential for interactions with CYP2C8 inhibitorsTiina Jaakkola, Jouko Laitila, Pertti J Neuvonen, et al.
Pharmacogenetics and Genomics|October 16, 2008
Effects of the SLCO1B1*1B haplotype on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinideAnnikka Kalliokoski, Janne T Backman, Pertti J Neuvonen, et al.
Trends in Pharmacological Sciences|April 6, 2012
Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implicationsAleksi Tornio, Mikko Niemi, Pertti J Neuvonen, et al.
The Histochemical Journal|November 27, 1999
Immunohistochemical detection of microsomal epoxide hydrolase in human synovial tissueJ T Backman, I Siegle, U M Zanger, et al.
Diabetologia|April 11, 2003
Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinideM Niemi, J T Backman, M Neuvonen, et al.
Clinical Pharmacology and Therapeutics|December 24, 2002
Gemfibrozil greatly increases plasma concentrations of cerivastatinJanne T Backman, Carl Kyrklund, Mikko Neuvonen, et al.
Clinical Pharmacology and Therapeutics|August 9, 2005
Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolitesJanne T Backman, Harri Luurila, Mikko Neuvonen, et al.
Basic & Clinical Pharmacology & Toxicology|September 10, 2011
Gender, but not CYP7A1 or SLCO1B1 polymorphism, affects the fasting plasma concentrations of bile acids in human beingsXiaoqiang Xiang, Janne T Backman, Pertti J Neuvonen, et al.
Basic & Clinical Pharmacology & Toxicology|May 23, 2022
Medicines, environment and clinical pharmacologyOuti Lapatto-Reiniluoto, Mia Siven, Janne T Backman, et al.
Pageof 23